Report Detail
Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2019-2025
- RnM3389272 |
- 07 May, 2019 |
- Global |
- 92 Pages |
- QYResearch |
- Other
Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.
In 2018, the global Anti-Neoplastic Pharmaceutical Agents market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Anti-Neoplastic Pharmaceutical Agents status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Neoplastic Pharmaceutical Agents development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Pfizer Inc.
Novartis AG
AstraZeneca
Gilead
Market segment by Type, the product can be split into
Hormones and Antagonists
Microorganism Products
Plant Products
Antitumor Antibiotics
Alkylating Agents
Antimetabolites
Natural Products
Market segment by Application, split into
Lung Cancer
Bladder Cancer
Breast Cancer
Cervical Cancer
Leukemia
Gynecological Cancer
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Anti-Neoplastic Pharmaceutical Agents status, future forecast, growth opportunity, key market and key players.
To present the Anti-Neoplastic Pharmaceutical Agents development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Anti-Neoplastic Pharmaceutical Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Hormones and Antagonists
- 1.4.3 Microorganism Products
- 1.4.4 Plant Products
- 1.4.5 Antitumor Antibiotics
- 1.4.6 Alkylating Agents
- 1.4.7 Antimetabolites
- 1.4.8 Natural Products
- 1.5 Market by Application
- 1.5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2014-2025)
- 1.5.2 Lung Cancer
- 1.5.3 Bladder Cancer
- 1.5.4 Breast Cancer
- 1.5.5 Cervical Cancer
- 1.5.6 Leukemia
- 1.5.7 Gynecological Cancer
- 1.5.8 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Anti-Neoplastic Pharmaceutical Agents Market Size
- 2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Regions
- 2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (2014-2025)
- 2.2.2 Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Anti-Neoplastic Pharmaceutical Agents Market Size by by Players
- 3.1.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue by by Players (2014-2019)
- 3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)
- 3.2 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served
- 3.3 Key Players Anti-Neoplastic Pharmaceutical Agents Product/Solution/Service
- 3.4 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2014-2019)
- 4.2 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2014-2019)
5 United States
- 5.1 United States Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
- 5.2 Anti-Neoplastic Pharmaceutical Agents Key Players in United States
- 5.3 United States Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 5.4 United States Anti-Neoplastic Pharmaceutical Agents Market Size by Application
6 Europe
- 6.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
- 6.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Europe
- 6.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 6.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application
7 China
- 7.1 China Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
- 7.2 Anti-Neoplastic Pharmaceutical Agents Key Players in China
- 7.3 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 7.4 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application
8 Japan
- 8.1 Japan Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
- 8.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Japan
- 8.3 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 8.4 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
- 9.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Southeast Asia
- 9.3 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 9.4 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application
10 India
- 10.1 India Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
- 10.2 Anti-Neoplastic Pharmaceutical Agents Key Players in India
- 10.3 India Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 10.4 India Anti-Neoplastic Pharmaceutical Agents Market Size by Application
11 Central & South America
- 11.1 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
- 11.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Central & South America
- 11.3 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 11.4 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application
12 International Players Profiles
- 12.1 GlaxoSmithKline plc.
- 12.1.1 GlaxoSmithKline plc. Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.1.5 GlaxoSmithKline plc. Recent Development
- 12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 F. Hoffmann-La Roche Ltd Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.2.5 F. Hoffmann-La Roche Ltd Recent Development
- 12.3 Eli Lilly and Company
- 12.3.1 Eli Lilly and Company Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.3.5 Eli Lilly and Company Recent Development
- 12.4 Bristol-Myers Squibb Company
- 12.4.1 Bristol-Myers Squibb Company Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.4.5 Bristol-Myers Squibb Company Recent Development
- 12.5 Becton, Dickinson and Company
- 12.5.1 Becton, Dickinson and Company Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.5.5 Becton, Dickinson and Company Recent Development
- 12.6 Pfizer Inc.
- 12.6.1 Pfizer Inc. Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.6.5 Pfizer Inc. Recent Development
- 12.7 Novartis AG
- 12.7.1 Novartis AG Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.7.5 Novartis AG Recent Development
- 12.8 AstraZeneca
- 12.8.1 AstraZeneca Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.8.5 AstraZeneca Recent Development
- 12.9 Gilead
- 12.9.1 Gilead Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Anti-Neoplastic Pharmaceutical Agents Introduction
- 12.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
- 12.9.5 Gilead Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Anti-Neoplastic Pharmaceutical Agents. Industry analysis & Market Report on Anti-Neoplastic Pharmaceutical Agents is a syndicated market report, published as Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Anti-Neoplastic Pharmaceutical Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
